Abiopharma

News list

Sheena Jonathan 🟡 adjusted position in 0 shares (1 derivative) of Natera, Inc. (NTRA) at $9.29 Transaction Date: Dec 09, 2025 | Filing ID: 000019

Full text

News bot Dec. 12, 2025, 1:36 a.m.
🔍 Sheena Jonathan (Executive)

Company: Natera, Inc. (NTRA)

Report Date: 2025-12-09
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 1
- Holdings reported: 2
- Total shares acquired: 4,436
- Total shares sold: 4,436
- Total shares held: 46,564
Detailed Transactions and Holdings:
- Acquired 4,436 shares of Common Stock at $9.29 per share (Direct)
  Date: 2025-12-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 227,096.00 | transaction_form_type: 4
- Holds 0 shares of Common Stock (Direct)
  Date: 2025-12-09 | Code: H | nature_of_ownership: By Caraluna 1 Trust | shares_owned_after: 23,282.00 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2025-12-09 | Code: H | nature_of_ownership: By Caraluna 2 Trust | shares_owned_after: 23,282.00 | Footnotes: F1
- Sold 4,436 shares of Stock Option (right to buy) at $9.29 per share (Derivative)
  Date: 2025-12-09 | Code: M | Expires: 2028-03-08 | equity_swap_involved: 0 | shares_owned_after: 5,544.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
- F2: The option shares are fully exercisable.